TY - JOUR
T1 - A Psychrophilic GelMA
T2 - Breaking Technical and Immunological Barriers for Multimaterial High-Resolution 3D Bioprinting
AU - Zaupa, Alessandro
AU - Terraza, Claudia
AU - Abarzúa-Illanes, Phammela N.
AU - Byres, Nicholas
AU - Zavala, Gabriela
AU - Cuenca, Jimena
AU - Hidalgo, Carmen
AU - Viafara-Garcia, Sergio M.
AU - Wolf, Bettina
AU - Pino-Lagos, Karina
AU - Blaker, Jonny J.
AU - Rumbak, Mayan
AU - Khoury, Maroun
AU - Enrione, Javier
AU - Acevedo, Juan Pablo
N1 - Publisher Copyright:
© 2022 The Authors. Published by American Chemical Society.
PY - 2022
Y1 - 2022
N2 - The increasing demand for tissue replacement has encouraged scientists worldwide to focus on developing new biofabrication technologies. Multimaterials/cells printed with stringent resolutions are necessary to address the high complexity of tissues. Advanced inkjet 3D printing can use multimaterials and attain high resolution and complexity of printed structures. However, a decisive yet limiting aspect of translational 3D bioprinting is selecting the befitting material to be used as bioink; there is a complete lack of cytoactive bioinks with adequate rheological, mechanical, and reactive properties. This work strives to achieve the right balance between resolution and cell support through methacrylamide functionalization of a psychrophilic gelatin and new fluorosurfactants used to engineer a photo-cross-linkable and immunoevasive bioink. The syntonized parameters following optimal formulation conditions allow proficient printability in a PolyJet 3D printer comparable in resolution to a commercial synthetic ink (∼150 μm). The bioink formulation achieved the desired viability (∼80%) and proliferation of co-printed cells while demonstrating in vivo immune tolerance of printed structures. The practical usage of existing high-resolution 3D printing systems using a novel bioink is shown here, allowing 3D bioprinted structures with potentially unprecedented complexity.
AB - The increasing demand for tissue replacement has encouraged scientists worldwide to focus on developing new biofabrication technologies. Multimaterials/cells printed with stringent resolutions are necessary to address the high complexity of tissues. Advanced inkjet 3D printing can use multimaterials and attain high resolution and complexity of printed structures. However, a decisive yet limiting aspect of translational 3D bioprinting is selecting the befitting material to be used as bioink; there is a complete lack of cytoactive bioinks with adequate rheological, mechanical, and reactive properties. This work strives to achieve the right balance between resolution and cell support through methacrylamide functionalization of a psychrophilic gelatin and new fluorosurfactants used to engineer a photo-cross-linkable and immunoevasive bioink. The syntonized parameters following optimal formulation conditions allow proficient printability in a PolyJet 3D printer comparable in resolution to a commercial synthetic ink (∼150 μm). The bioink formulation achieved the desired viability (∼80%) and proliferation of co-printed cells while demonstrating in vivo immune tolerance of printed structures. The practical usage of existing high-resolution 3D printing systems using a novel bioink is shown here, allowing 3D bioprinted structures with potentially unprecedented complexity.
UR - http://www.scopus.com/inward/record.url?scp=85144746712&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/a966af05-b8c1-3b99-bcd2-2e3b3521eb44/
U2 - 10.1021/acs.biomac.2c01019
DO - 10.1021/acs.biomac.2c01019
M3 - Article
C2 - 36542545
AN - SCOPUS:85144746712
SN - 1525-7797
VL - 24
SP - 150
EP - 165
JO - Biomacromolecules
JF - Biomacromolecules
IS - 1
ER -